Baxter International Inc. last reported quarterly results on Oct 29, 2026, for Q3 FY2026 (the quarter ended Sep 30, 2026): revenue of $3.0 billion (+5.0% year over year) and diluted EPS of $0.57. It usually reports 29–43 days after a quarter ends. Based on that pattern, the next release is estimated for around Feb 11, 2027.
Results for Q4 FY2026, the quarter ending around Dec 31, 2026. Expected on a Thursday. Based on last year's release for the same quarter on Feb 12, 2026. This is an estimate, not a date the company has announced.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 29–43 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Oct 29, 2026
29 days after quarter end
|
Q3 FY2026
ended Sep 30, 2026
|
2,976
+5.0%
|
294
+739.1%
|
0.57
+733.3%
|
|
Jul 30, 2026
30 days after quarter end
|
Q2 FY2026
ended Jun 30, 2026
|
2,960
+5.3%
|
126
+38.5%
|
0.24
+33.3%
|
|
Apr 30, 2026
30 days after quarter end
|
Q1 FY2026
ended Mar 31, 2026
|
2,701
+2.9%
|
-15
-111.9%
|
-0.03
-112.0%
|
|
Feb 12, 2026
43 days after quarter end
|
Q4 FY2025
ended Dec 31, 2025
|
2,974
+8.0%
|
-1,128
-120.3%
|
-2.21
-121.2%
|
|
Oct 30, 2025
30 days after quarter end
|
Q3 FY2025
ended Sep 30, 2025
|
2,835
+5.0%
|
-46
-132.9%
|
-0.09
-133.3%
|
|
Jul 31, 2025
31 days after quarter end
|
Q2 FY2025
ended Jun 30, 2025
|
2,810
+4.3%
|
91
+129.0%
|
0.18
+129.5%
|
|
May 1, 2025
31 days after quarter end
|
Q1 FY2025
ended Mar 31, 2025
|
2,625
+5.4%
|
126
+240.5%
|
0.25
+257.1%
|
|
Feb 3, 2025
34 days after quarter end
|
Q4 FY2024
ended Dec 31, 2024
|
2,753
+0.9%
|
-512
-309.0%
|
-1.00
-308.3%
|
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- BAX (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Deerfield, IL
- SEC filer status
- Large accelerated filer
- SEC CIK
- 10456
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.